This article examines how IHC-based approaches are not only pivotal for neurodegenerative disorders but are also transformative across a spectrum of human diseases, including cancer and infectious diseases.

What elevates immunohistochemistry (IHC) to extraordinary precision? The answer is HRP polymer detection—a highly sensitive, streamlined method revolutionizing signal detection in IHC. In this article, we’ll dive into how it works, how it stacks up against traditional methods, and why it might be the right choice for your lab.

In the fast-paced world of in vitro diagnostics (IVD), antibodies are the cornerstone of reliable diagnostic tests, powering everything from ELISA to lateral flow assays and multiplex immunoassays. Developing high-performance antibody pairs—crucial for accurate diagnostics—has traditionally been a slow, labor-intensive, and costly process. Enter artificial intelligence (AI), which is transforming this landscape by accelerating and refining the discovery, optimization, and validation of IVD antibody pairs. Here's how AI is reshaping the future of diagnostics.

For years, Alzheimer’s disease (AD) has remained a formidable challenge for patients, families, and researchers. One of the most heartbreaking realities for many is the phrase: “There is no cure.” Although several new treatments have emerged over the past few decades, options that tangibly improve memory and cognitive function in daily life remain limited.

Antibodies are research powerhouses, but batch-to-batch variability can derail experiments. Recombinant monoclonal antibodies (mAbs) are often touted as the
consistency champions. But are they always the best choice? Let's cut through the noise.

Alzheimer’s disease (AD) remains a devastating challenge, robbing millions worldwide of their memories and independence. For decades, treatments only addressed symptoms—until now. Enter Kisunla (donanemab-azbt), a groundbreaking therapy from Eli Lilly that targets the root cause of AD: toxic amyloid plaques in the brain. This isn’t just another drug; it’s a paradigm shift offering real hope.